📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Effectiveness and survival of methotrexate versus adalimumab in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). (2023)

First Author: Alabas OA

Attributed to: MICA: Psoriasis Stratification to Optimise Relevant Therapy (PSORT) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/bjd/ljad179

PubMed Identifier: 37226927

Publication URI: http://europepmc.org/abstract/MED/37226927

Type: Journal Article/Review

Volume: 189

Parent Publication: The British journal of dermatology

Issue: 3

ISSN: 0007-0963